Early Multi-Target Treatment of Mild-to-Moderate COVID-19, Particularly in Terms of Non-Steroidal Anti-Inflammatory Drugs and Indomethacin. - Fazio, Serafino; Bellavite, Paolo (BioMed, 2023)